FR2270853B1 - - Google Patents

Info

Publication number
FR2270853B1
FR2270853B1 FR7515190A FR7515190A FR2270853B1 FR 2270853 B1 FR2270853 B1 FR 2270853B1 FR 7515190 A FR7515190 A FR 7515190A FR 7515190 A FR7515190 A FR 7515190A FR 2270853 B1 FR2270853 B1 FR 2270853B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7515190A
Other versions
FR2270853A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of FR2270853A1 publication Critical patent/FR2270853A1/fr
Application granted granted Critical
Publication of FR2270853B1 publication Critical patent/FR2270853B1/fr
Expired legal-status Critical Current

Links

FR7515190A 1974-05-15 1975-05-15 Expired FR2270853B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2270974 1974-05-15

Publications (2)

Publication Number Publication Date
FR2270853A1 FR2270853A1 (fr) 1975-12-12
FR2270853B1 true FR2270853B1 (fr) 1978-09-08

Family

ID=11199496

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7515190A Expired FR2270853B1 (fr) 1974-05-15 1975-05-15

Country Status (4)

Country Link
JP (1) JPS5123248A (fr)
DE (1) DE2521113A1 (fr)
FR (1) FR2270853B1 (fr)
GB (1) GB1461240A (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
GEP20074134B (en) 2002-08-19 2007-06-25 Pfizer Prod Inc Combination therapy for hyperproliferative diseases
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
EP1601669B1 (fr) 2003-03-07 2008-12-24 Schering Corporation Composes d'azetidinone substitues, leurs formulations et leur utilisation pour traiter l'hypercholesterolemie
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
JPS5123248A (en) 1976-02-24
FR2270853A1 (fr) 1975-12-12
DE2521113A1 (de) 1976-03-18
GB1461240A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
FR2255875B1 (fr)
FR2290795B1 (fr)
BR7501663A (fr)
FR2270853B1 (fr)
FR2256979B1 (fr)
FR2261911B1 (fr)
FI751750A (fr)
DE2448515C3 (fr)
FR2285418B2 (fr)
JPS50106725A (fr)
FR2293805B1 (fr)
FR2264538A1 (fr)
CS165426B1 (fr)
IN141084B (fr)
FI740277A0 (fr)
JPS50100290U (fr)
JPS50102553A (fr)
CH435974A4 (fr)
BG22576A1 (fr)
CH587384B5 (fr)
CH580883A5 (fr)
CH561943A5 (fr)
CH44075A4 (fr)
BG21508A1 (fr)
CH363074A4 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse